Corning Acquires Optical Biosensor Patent Rights from Oerlikon

17-Aug-2007

Corning Incorporated announced that it has acquired from Oerlikon the worldwide exclusive rights to U.S. Patent 5,738,825 and its foreign counterparts, which cover microplate-based optical biosensors. Corning had previously acquired a joint ownership right in the patent from Artificial Sensing Instruments, AG of Switzerland as part of a broader technology exchange. By acquiring these exclusive rights in the patent from Oerlikon, Corning will not only have the right to continue to practice the technology disclosed, but will now also have the full right to enforce the patent.

"We are pleased to expand our portfolio of enforceable patents as we continue to invest in this exciting commercial opportunity," stated Dr. Jeff Mooney, commercial technology director for Corning Life Sciences.

Other news from the department business & finance

These products might interest you

Octet R2 / Octet R4 / Octet R8

Octet R2 / Octet R4 / Octet R8 by Sartorius

Full power on 2, 4 or 8 channels: Label-free and GxP-compliant analysis of molecular interactions

Innovative label-free real-time protein quantification, binding kinetics and rapid screenings

protein analyzers
Octet SF3

Octet SF3 by Sartorius

Surface Plasmon Resonance (SPR) using Single Dynamic Injections for Kinetics and Affinities

Curvature is Key - Adding a ‘Third Dimension’ to the Binding Curve

Octet RH16 and RH96

Octet RH16 and RH96 by Sartorius

Efficient protein analysis for process optimisation and manufacturing control in high-throughput

Label-free protein quantification and characterization of protein-protein interactions

protein analyzers
Loading...

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy